News and Insights of 3D Printing and Manufacturing
Advanced Development of Additive Manufacturing (A.D.A.M.) is on the cusp of releasing 3D-printed bioresorbable bone implants. The implants would, if successful, be completely absorbed by the body. Recovery times would improve; patients would undergo fewer surgeries; the implant is personalized to each patient.
3D Systems significantly expanded its focus on regenerative medicine and bioprinting solutions after reducing its workforce to concentrate on the healthcare AM sector. The expanded focus follows on great progress made in the development of 3D printing systems for solid-organ scaffolds. This progress is the product of collaboration between 3D Systems, United Therapeutics Corporation and UTC’s organ manufacturing and transplantation-focused subsidiary, Lung Biotechnology PBC. 3D Systems intends to leverage this work and accomplishments with other partners to invest, further develop and commercialize solutions for regenerative medicine. Applications of its R&D program include the development of non-solid organ applications requiring biologically sustainable vasculature.